Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Całbecka · SciRah

Researcher profile · Semantic Scholar

M. Całbecka

Share profile

M. Całbecka — researcher profile on SciRah

h-index: 14
Works: 47
Citations: 1,008

Most-cited papers

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
T. Robak, J. Błoński, J. Góra-Tybor, K. Jamroziak +15 more
2006Blood134 citations
Semantic Scholar
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
R. Hájek, T. Masszi, M. Petrucci, A. Palumbo +28 more
2016Leukemia116 citations Open access
Semantic Scholar
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
T. Robak, K. Jamroziak, J. Góra-Tybor, B. Stella-Holowiecka +16 more
2010Journal of Clinical Oncology103 citations Open access
Semantic Scholar
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1‐PDGFRA‐expressing patients
G. Helbig, B. Stella-Holowiecka, M. Majewski, M. Całbecka +6 more
2008British Journal of Haematology94 citations Open access
Semantic Scholar
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
T. Robak, J. Błoński, J. Góra-Tybor, M. Kasznicki +12 more
2004European Journal of Cancer75 citations
Semantic Scholar
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
T. Robak, K. Jamroziak, J. Góra-Tybor, J. Błoński +25 more
2006Blood74 citations Open access
Semantic Scholar
Immunogenicity of influenza vaccine in patients with hemato-oncological disorders.
L. Brydak, M. Całbecka
1999Leukemia and Lymphoma51 citations
Semantic Scholar
CD38 Gene Polymorphisms Contribute to Genetic Susceptibility to B-Cell Chronic Lymphocytic Leukemia: Evidence from Two Case-Control Studies in Polish Caucasians
K. Jamroziak, Zofia Szemraj, O. Grzybowska-Izydorczyk, J. Szemraj +12 more
2009Cancer Epidemiology, Biomarkers and Prevention41 citations Open access
Semantic Scholar
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment
J. Góra-Tybor, E. Mędraś, M. Całbecka, A. Kołkowska-Leśniak +3 more
2015Leukemia and Lymphoma40 citations
Semantic Scholar
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
M. Libura, S. Giebel, B. Piątkowska-Jakubas, M. Pawelczyk +26 more
2016Blood39 citations Open access
Semantic Scholar
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia
T. Robak, J. Błoński, M. Kasznicki, J. Góra-Tybor +13 more
2001Leukemia37 citations Open access
Semantic Scholar
A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations
H. Janiszewska, A. Bąk, M. Pilarska, Marta Heise +7 more
2012Haematologica25 citations Open access
Semantic Scholar
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1‐PDGFRA fusion transcript—results of Polish multicentre study
G. Helbig, Andrzej Moskwa, M. Hus, J. Piszcz +9 more
2010Hematological Oncology25 citations
Semantic Scholar
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
G. Helbig, Andrzej Moskwa, M. Hus, J. Piszcz +8 more
2011Cancer Chemotherapy and Pharmacology21 citations Open access
Semantic Scholar
The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera
H. Janiszewska, A. Bąk, Martyna Hartwig, M. Kuliszkiewicz‐Janus +4 more
2016British Journal of Haematology14 citations
Semantic Scholar
Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1‐PDGFRA fusion transcript: extended follow‐up
G. Helbig, Andrzej Moskwa, A. Świderska, A. Urbanowicz +6 more
2009British Journal of Haematology14 citations
Semantic Scholar
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study
B. Budziszewska, A. Pluta, K. Sułek, A. Wierzbowska +23 more
2015Leukemia and Lymphoma11 citations
Semantic Scholar
The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study
S. Grosicki, J. Hołowiecki, S. Giebel, S. Kyrcz-Krzemień +9 more
2011American journal of hematology/oncology11 citations Open access
Semantic Scholar
Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia
Anna Marta Madejczyk, F. Canzian, J. Góra-Tybor, D. Campa +9 more
2022Frontiers in Oncology9 citations Open access
Semantic Scholar
Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.
T. Robak, J. Błoński, J. Góra-Tybor, M. Kasznicki +15 more
20049 citations
Semantic Scholar
Randomized Comparison of Weekly Administration and Daily Courses of Cladribine in Patients with Hairy Cell Leukemia - Updated Results.
T. Robak, M. Kasznicki, J. Góra-Tybor, J. Dwilewicz-Trojaczek +12 more
20048 citations
Semantic Scholar
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
E. Iskierka-Jażdżewska, F. Canzian, A. Stępień, A. Martino +26 more
2019Leukemia and Lymphoma7 citations Open access
Semantic Scholar
Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia.
J. Zaucha, E. Wyrowińska, W. Prejzner, M. Całbecka +1 more
2006Clinical and Laboratory Haematology7 citations
Semantic Scholar
A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial
H. Gisslinger, V. Buxhofer-Ausch, Juri Hodisch, A. Radinoff +18 more
2019British Journal of Haematology6 citations Open access
Semantic Scholar
Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium
E. Iskierka-Jażdżewska, A. Stępień, F. Canzian, A. Martino +25 more
20146 citations Open access
Semantic Scholar
Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.
T. Robak, J. Błoński, J. Góra-Tybor, J. Najda +18 more
20056 citations
Semantic Scholar
Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia
T. Robak, J. Błoński, J. Góra-Tybor, M. Całbecka +17 more
2014Leukemia and Lymphoma5 citations Open access
Semantic Scholar
CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis.
M. Libura, M. Pawelczyk, I. Florek, K. Matiakowska +26 more
2015Blood Cells, Molecules & Diseases4 citations Open access
Semantic Scholar
Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine‐based regiments or chlorambucil – follow‐up of PALG‐CLL randomized trials
J. Błoński, T. Robak, K. Chojnowski, J. Góra-Tybor +21 more
2013European Journal of Haematology4 citations Open access
Semantic Scholar
Real-Life Comparison Of Severe Vascular Events and Other Non-Hematological Complications In CML Patients Treated With Second Line Nilotinib Or Dasatinib
J. Góra-Tybor, E. Mędraś, M. Całbecka, Agnieszka Kołkowska +3 more
20133 citations
Semantic Scholar
Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).
T. Robak, J. Błoński, K. Jamroziak, J. Góra-Tybor +25 more
20083 citations
Semantic Scholar
Randomized Comparison of Cladribine Plus Cyclophsophamide with Fludarabine Plus Cyclophosphamide in Progressive Chronic Lymphocytic Leukemia: An Updated Report of Prospective PALG-CLL3 Study.
T. Robak, J. Błoński, J. Góra-Tybor, K. Jamroziak +19 more
20063 citations
Semantic Scholar
Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study,
T. Robak, J. Błoński, K. Jamroziak, M. Całbecka +17 more
20112 citations
Semantic Scholar
Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Cladribine
J. Błoński, T. Robak, J. Treliński, K. Chojnowski +22 more
20082 citations
Semantic Scholar
Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.
B. Budziszewska, A. Pluta, K. Sułek, T. Robak +21 more
20101 citations
Semantic Scholar
Long-Term Remission Maintenance on Weekly Imatinib Dosage In Patients with FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukaemia
G. Helbig, M. Hus, Andrzej Moskwa, K. Zawilska +10 more
20101 citations
Semantic Scholar
Primary myelofibrosis with normal karyotype and cryptic aberrations detected by FISH: case report
K. Osmańska, B. Mucha, Katarzyna Skonieczka, A. Bartoszewska-Kubiak +2 more
20180 citations Open access
Semantic Scholar
Long-term follow-up of imatinib mesylate for hypereosinophilic syndromes harbouring FIP1L1-PDGFRA fusion
G. Helbig, M. Hus, A. Soja, A. Świderska +15 more
20150 citations
Semantic Scholar
Favorable outcome of patients with normal karyotype acute myeloid leukemia harboring FLT3-ITD and treated with cladribine added to daunorubicin and cytarabine induction
M. Libura, S. Giebel, B. Piątkowska-Jakubas, M. Pawelczyk +25 more
20150 citations
Semantic Scholar
Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)
A. Stępień, A. Martino, F. Canzian, D. Campa +14 more
20140 citations
Semantic Scholar
FLT3 -ITD mutation and its correlations with clinical and hematological features in adult patients with acute myeloid leukemia – preliminary report
K. Matiakowska, M. Morgut-Klimkowska, A. Bartoszewska-Kubiak, K. Soszyńska +7 more
20130 citations
Semantic Scholar
randomized trial of the Polish Adult Leukemia Group (PALG CLL2) chronic lymphocytic leukemia: report of a prospective, multicenter, cyclophosphamide plus mitoxantrone in the treatment of progressive Cladribine alone and in combination with cyclophosphamide or
M. Kasznicki, M. Całbecka, K. Zawilska, K. Kuliczkowski +12 more
20130 citations
Semantic Scholar
Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
I. Solarska, B. Nasiłowska-Adamska, M. Bieniaszewska, J. Zaucha +6 more
20090 citations
Semantic Scholar
Imatinib at Weekly Dosage May Induce and Maintain Haematologic and Molecular Remission in Chronic Eosinophilic Leukemia Harbouring FIP1L1-PDGFRA Fusion Gene- An Extended Follow-up Study.
G. Helbig, M. Całbecka, Justyna Gajkowska, Andrzej Moskwa +4 more
20080 citations
Semantic Scholar
Monitoring of BCR-ABL mRNA in patients with chronic myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
I. Solarska, B. Nasiłowska-Adamska, J. Zaucha, P. Rzepecki +6 more
20070 citations
Semantic Scholar
Prognostic Value of BCR-ABL Transcript Amount for Early Relapse Detection in Chronic Myeloid Leukemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
I. Solarska, M. Majewski, B. Nasiłowska-Adamska, J. Zaucha +6 more
20070 citations
Semantic Scholar
Epidemiology of acute leukemia in adults in Poland in 2004-2006
I. Seferyńska, E. Orłowska, A. Ejduk, S. Maj +21 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Warzocha×24
Invite
K. Warzocha — researcher profile on SciRah
T. Robak×23
Invite
T. Robak — researcher profile on SciRah
J. Góra-Tybor×18
Invite
J. Góra-Tybor — researcher profile on SciRah
K. Sułek×18
Invite
K. Sułek — researcher profile on SciRah

K. Kuliczkowski

×18

Invite

K. Kuliczkowski — researcher profile on SciRah

A. Dmoszýnska×16

Invite

A. Dmoszýnska — researcher profile on SciRah

Invite

J. Kloczko — researcher profile on SciRah

B. Stella-Holowiecka×16

Invite

B. Stella-Holowiecka — researcher profile on SciRah

A. Skotnicki×16

Invite

A. Skotnicki — researcher profile on SciRah

K. Jamroziak×15

Invite

K. Jamroziak — researcher profile on SciRah

K. Zawilska×15

Invite

K. Zawilska — researcher profile on SciRah

J. Błoński×14

Invite

J. Błoński — researcher profile on SciRah